To build on that, there are two parts to the regulations I was talking about. One of them is Health Canada approval. Health Canada is a world-renowned organization in terms of the quality of the work they do, but they are strapped at Health Canada and things end up taking longer and the approval time is relatively unknown. There is also cost recovery, which particularly damages the small organizations in terms of going to them. They put in, they pay their fee, and they don't know when their product is going to come out of the process. If we were able to help Health Canada with that, it would be a true benefit for the small organizations.
The second part was the health technology assessment. It seems that most provinces do that. Even nationally there is CADTH, and various hospitals are all doing their own health technology assessment. Everybody who understands health technology assessments to any degree gets it for pharmaceuticals. It's a lot easier. The system of utilization is so important for medical devices. There are differences. The sad part is we do have MaRS EXCITE and we do have OTACH, which are model processes in the world. We're not getting that to go across Canada and have other people adopting it. It's a bit of “it's not invented here”. It's a bit of a paradigm shift. We have 14 separate health care systems, so it's getting everybody to look together and ask how they can share these best practices and what works.